Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Recurrent venous thromboembolism · people > 18 years of age with a diagnosed deep vein thrombosis

Idrabiotaparinux showed no clear difference in recurrent venous thromboembolism compared with idraparinux (low certainty).

1 finding from 1 review

Pentasaccharides for the treatment of deep vein thrombosis 2017 · Cochrane Headline outcomes only
RR 0.72 [0.31, 1.69]
1 study · 757 participants
Low